Company: LICN
Filing Date: 2025-04-29
Form Type: 20-F
Source: 0001213900-25-036244
Chunk: 28

Company: Lichen International Ltd
Filing Date: 2025-04-29
Form: 20-F
Item: Item 4A
Chunk 28
---
            557      $         10,766  
  Net cash used in investing activities                                                  (9,888                (9,865                (2,842  
  Net cash provided by (used in) financing activities                                    13,087                14,098                  (327  
  Effects of exchange rate changes on cash                                                3,229                (1,533                (1,843  
  Net increase in cash                                     $                                856      $          3,257      $          5,754  

Operating Activities:

Net cash used in operating activities was approximately $5.57 million
for the year ended December 31, 2024, as compared to net cash provided by operating activities was approximately $0.56 million for the
year ended December 31, 2023. For the year ended December 31, 2024, net cash used in operating activities was mainly resulted from the
net loss of $6.12 million, and the depreciation of property and equipment and the amortization of intangible, right-of-use and other assets
in the amount of approximately $2.99 million, share-based compensation in the amount of approximately $3.41 million and accounts receivable
in the amount of $0.64 million, offset by the prepayments and other current assets in the amount of approximately $4.75 million, accrued
liabilities and other current liabilities in the amount of approximately $0.71 million and taxes payable in the amount of approximately
$0.60 million. Net cash provided by operating activities was approximately $0.56 million for the year ended December 31, 2023, as compared
to approximately $10.77 million for the year ended December 31, 2022. For the year ended December 31, 2023, net cash provided by operating
activities was mainly resulted from the net income of $8.34 million, and the depreciation of property and equipment and the amortization
of intangible, right-of-use and other assets in the amount of approximately $3.00 million and the deferred IPO costs in the amount of
approximately $1.10 million offset by the accounts receivable in the amount of $0.98 million, prepayments and other current assets in
the amount of $9.70 million and the due to the related parties in the amount of approximately $1.07 million. For the year ended December
31, 2022, net cash provided by operating activities was mainly resulted